BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 1659529)

  • 41. Signal transduction systems in growth hormone-releasing hormone and somatostatin release from perifused rat hypothalamic fragments.
    Cugini CD; Millard WJ; Leidy JW
    Endocrinology; 1991 Sep; 129(3):1355-62. PubMed ID: 1678698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activin-A modulates growth hormone secretion from cultures of rat anterior pituitary cells.
    Bilezikjian LM; Corrigan AZ; Vale W
    Endocrinology; 1990 May; 126(5):2369-76. PubMed ID: 2158424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of cyclic AMP- and calcium-dependent mechanisms in the regulation of growth hormone-releasing hormone-stimulated growth hormone release from ovine pituitary cells.
    Sartin JL; Coleman ES; Steele B
    Domest Anim Endocrinol; 1996 May; 13(3):229-38. PubMed ID: 8738864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triiodothyronine (T3) inhibition of growth hormone secretion by chicken pituitary cells in vitro.
    Donoghue DJ; Scanes CG
    Gen Comp Endocrinol; 1991 Dec; 84(3):344-54. PubMed ID: 1725515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatostatin partially reverses desensitization of somatotrophs induced by growth hormone-releasing factor.
    Clayton RN; Bailey LC
    J Endocrinol; 1987 Jan; 112(1):69-76. PubMed ID: 2880921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture.
    Soto JL; Castrillo JL; Dominguez F; Dieguez C
    Endocrinology; 1995 Sep; 136(9):3863-70. PubMed ID: 7649093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone (GH)-releasing peptide and GH releasing hormone stimulate GH release from subpopulations of somatotrophs in rats.
    Mitani M; Kaji H; Abe H; Chihara K
    J Neuroendocrinol; 1996 Nov; 8(11):825-30. PubMed ID: 8933359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly.
    Alster DK; Bowers CY; Jaffe CA; Ho PJ; Barkan AL
    J Clin Endocrinol Metab; 1993 Sep; 77(3):842-5. PubMed ID: 8370708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ceramide enhances growth hormone (GH)-releasing hormone-stimulated cyclic adenosine 3',5'-monophosphate accumulation but inhibits GH release in rat anterior pituitary cells.
    Negishi T; Chik CL; Ho AK
    Endocrinology; 1999 Dec; 140(12):5691-7. PubMed ID: 10579333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
    Fairhall KM; Mynett A; Robinson IC
    J Endocrinol; 1995 Mar; 144(3):555-60. PubMed ID: 7738479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone and prolactin secretion in cultured somatomammotroph cells.
    Kashio Y; Chomczynski P; Downs TR; Frohman LA
    Endocrinology; 1990 Sep; 127(3):1129-35. PubMed ID: 1974845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
    Bercu BB; Yang SW; Masuda R; Walker RF
    Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6.
    Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist.
    Wu D; Chen C; Katoh K; Zhang J; Clarke IJ
    J Endocrinol; 1994 Feb; 140(2):R9-13. PubMed ID: 8169551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of gonadotropin-releasing hormone, dopamine and somatostatin and their second messengers on the mRNA levels of gonadotropin II beta subunit and growth hormone in the teleost fish, tilapia.
    Melamed P; Gur G; Elizur A; Rosenfeld H; Sivan B; Rentier-Delrue F; Yaron Z
    Neuroendocrinology; 1996 Oct; 64(4):320-8. PubMed ID: 8895862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired generation of cyclic adenosine 3',5'-monophosphate in a somatomammotroph cell line derived from dwarf (dw) rat anterior pituitaries.
    Brain CE; Chomczynski P; Downs TR; Frohman LA
    Endocrinology; 1991 Dec; 129(6):3410-6. PubMed ID: 1659531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.
    Roh SG; He ML; Matsunaga N; Hidaka S; Hidari H
    J Anim Sci; 1997 Oct; 75(10):2749-53. PubMed ID: 9331880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phorbol ester, phorbol 12-myristate 13-acetate, and a calcium ionophore, A23187, can mimic the luteolytic effect of prostaglandin F2 alpha in isolated rat luteal cells.
    Baum MS; Rosberg S
    Endocrinology; 1987 Mar; 120(3):1019-26. PubMed ID: 3026783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 12-O-tetradecanoyl phorbol-13-acetate stimulates rat growth hormone (GH) release through different pathways from that of human pancreatic GH-releasing factor.
    Ohmura E; Friesen HG
    Endocrinology; 1985 Feb; 116(2):728-33. PubMed ID: 2981678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent.
    Brown OA; Sosa YE; Dardenne M; Pléau J; Goya RG
    Neuroendocrinology; 1999 Jan; 69(1):20-7. PubMed ID: 9892847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.